methyleugenol has been researched along with Reperfusion Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, NQ; Hou, SH; Kuang, BC; Li, QW; Sun, KL; Wang, MQ; Wang, ZH; Zhan, GJ; Zhang, JS | 1 |
| Gong, N; Hou, S; Kuang, B; Li, Q; Sun, K; Wang, M; Wang, MMZ; Zhang, J | 1 |
| El-Shorbagy, HM; Saleh, H | 1 |
3 other study(ies) available for methyleugenol and Reperfusion Injury
| Article | Year |
|---|---|
[Effect of methyl eugenol on hypoxia/reoxygenation injury of human renal tubular epithelial cells and its mechanism].
Topics: Apoptosis; Epithelial Cells; Eugenol; Heme Oxygenase-1; Humans; Hypoxia; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury | 2021 |
Methyl eugenol attenuates liver ischemia reperfusion injury via activating PI3K/Akt signaling.
Topics: Animals; Cell Line; Chromones; Disease Models, Animal; Eugenol; Hepatocytes; Humans; Liver; Male; Mice; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Signal Transduction; Warm Ischemia | 2021 |
Mechanism underlying methyl eugenol attenuation of intestinal ischemia/reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Caspase 3; Disease Models, Animal; Eugenol; Inflammation Mediators; Interleukin-6; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; Oxidative Stress; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |